- Home
- USLM vs PCVX Comparison
USLM vs PCVX Comparison
Compare USLM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- PCVX
- Stock Information
- Founded
- USLM 1948
- PCVX 2013
- Country
- USLM United States
- PCVX United States
- Employees
- USLM N/A
- PCVX N/A
- Industry
- USLM Other Metals and Minerals
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- PCVX Health Care
- Exchange
- USLM Nasdaq
- PCVX Nasdaq
- Market Cap
- USLM 3.6B
- PCVX 4.0B
- IPO Year
- USLM N/A
- PCVX 2020
- Fundamental
- Price
- USLM $127.43
- PCVX $32.10
- Analyst Decision
- USLM
- PCVX Strong Buy
- Analyst Count
- USLM 0
- PCVX 8
- Target Price
- USLM N/A
- PCVX $114.17
- AVG Volume (30 Days)
- USLM 118.7K
- PCVX 1.6M
- Earning Date
- USLM 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- USLM 0.19%
- PCVX N/A
- EPS Growth
- USLM 44.81
- PCVX N/A
- EPS
- USLM 4.36
- PCVX N/A
- Revenue
- USLM $352,260,000.00
- PCVX N/A
- Revenue This Year
- USLM $22.64
- PCVX N/A
- Revenue Next Year
- USLM $8.38
- PCVX N/A
- P/E Ratio
- USLM $29.60
- PCVX N/A
- Revenue Growth
- USLM 21.97
- PCVX N/A
- 52 Week Low
- USLM $80.47
- PCVX $27.66
- 52 Week High
- USLM $159.53
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- USLM 61.48
- PCVX 48.43
- Support Level
- USLM $119.42
- PCVX $31.47
- Resistance Level
- USLM $132.11
- PCVX $33.16
- Average True Range (ATR)
- USLM 3.60
- PCVX 1.33
- MACD
- USLM -0.07
- PCVX 0.01
- Stochastic Oscillator
- USLM 65.28
- PCVX 41.49
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.